Valion Bio VBIO
NASDAQ VBIO
$0.12 0.00 (-1.88%)
As of: Aug 21, 2026 · 2:30 PM EDT

Valion Bio (VBIO) Gross Profit (2021 - 2026)

Valion Bio (VBIO) posted quarterly Gross Profit of $73000.0 for Q4 2025, up 130.54% year-over-year from $31664.2 in Q4 2024, and up 150.34% quarter-over-quarter from -$145000.0 in Q3 2025.

Valion Bio (VBIO) Gross Profit (2021 - 2026) Analysis & Trends

Valion Bio's Gross Profit history runs 5 years deep, the most recent figure standing at $73000.0 for Q4 2025.

  • In Q4 2025, Gross Profit rose 130.54% year-over-year to $73000.0; the TTM figure through Dec 2025 stood at $32000.0 (up 1500.0% YoY), while the FY2025 annual figure was $32000.0, up 1500.0% from the prior year.
  • Gross Profit for Q4 2025 stood at $73000.0, up from -$145000.0 in the prior quarter.
  • The five-year high for Gross Profit was $167000.0 in Q1 2024, with the low at -$239000.0 in Q4 2024.
  • The 5-year median for Gross Profit is $47000.0 (2024), against an average of $29150.0.
  • The sharpest annual moves came in 2022 and 2024: Gross Profit jumped 2250.0% in 2022, then sank 4880.0% in 2024.
  • Valion Bio's Gross Profit stood at -$2000.0 in 2021, then surged by 2250.0% to $43000.0 in 2022, then slumped by 88.37% to $5000.0 in 2023, then tumbled by 4880.0% to -$239000.0 in 2024, then soared by 130.54% to $73000.0 in 2025.
  • Business Quant data shows VBIO's Gross Profit at $73000.0 in Q4 2025, -$145000.0 in Q3 2025, and $54000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.81 Bn 130.96 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.07 Bn 78.08 Bn 3.93 Bn
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn
4 Moderna 55.64 Bn 50.50 Bn 52.00 Mn
5 BeOne Medicines 41.99 Bn 36.89 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.68 Bn 28.37 Bn 992.69 Mn
7 BioNTech SE 27.69 Bn 9.29 Bn 668.28 Mn
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.36 Bn 26.52 Bn -
10 Valion Bio 404,923.65 -1.80 Mn -45,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -45,000.00
Jun 30, 2026 -45,000.00
Dec 31, 2025 73,000.00
Dec 31, 2025 73,000.00
Sep 30, 2025 -145,000.00
Sep 30, 2025 -145,000.00
Jun 30, 2025 54,000.00
Jun 30, 2025 54,000.00
Mar 31, 2025 50,000.00
Mar 31, 2025 50,000.00
Dec 31, 2024 -239,000.00
Dec 31, 2024 -239,000.00
Sep 30, 2024 44,000.00
Sep 30, 2024 44,000.00
Jun 30, 2024 30,000.00
Jun 30, 2024 30,000.00
Mar 31, 2024 167,000.00
Mar 31, 2024 167,000.00
Dec 31, 2023 5,000.00
Dec 31, 2023 5,000.00